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Abstract
Acrosomal exocytosis is a calcium-regulated exocytosis that can be triggered by PKC activators. The involvement of PKC in
acrosomal exocytosis has not been fully elucidated, and it is unknown if MARCKS, the major substrate for PKC, participates
in this exocytosis. Here, we report that MARCKS is expressed in human spermatozoa and localizes to the sperm head and
the tail. Calcium- and phorbol ester-triggered acrosomal exocytosis in permeabilized sperm was abrogated by different anti-
MARCKS antibodies raised against two different domains, indicating that the protein participates in acrosomal exocytosis.
Interestingly, an anti-phosphorylated MARCKS antibody was not able to inhibit secretion. Similar results were obtained
using recombinant proteins and phospho-mutants of MARCKS effector domain (ED), indicating that phosphorylation
regulates MARCKS function in acrosomal exocytosis. It is known that unphosphorylated MARCKS sequesters PIP2. This
phospholipid is the precursor for IP3, which in turn triggers release of calcium from the acrosome during acrosomal
exocytosis. We found that PIP2 and adenophostin, a potent IP3-receptor agonist, rescued MARCKS inhibition in
permeabilized sperm, suggesting that MARCKS inhibits acrosomal exocytosis by sequestering PIP2 and, indirectly, MARCKS
regulates the intracellular calcium mobilization. In non-permeabilized sperm, a permeable peptide of MARCKS ED also
inhibited acrosomal exocytosis when stimulated by a natural agonist such as progesterone, and pharmacological inducers
such as calcium ionophore and phorbol ester. The preincubation of human sperm with the permeable MARCKS ED
abolished the increase in calcium levels caused by progesterone, demonstrating that MARCKS regulates calcium
mobilization. In addition, the phosphorylation of MARCKS increased during acrosomal exocytosis stimulated by the same
activators. Altogether, these results show that MARCKS is a negative modulator of the acrosomal exocytosis, probably by
sequestering PIP2, and that it is phosphorylated during acrosomal exocytosis.
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Introduction
The acrosomal exocytosis is a calcium-regulated secretion
required for physiological fertilization in mammalian sperm [1].
During this synchronized and tightly regulated process, the outer
membrane of the acrosome and the plasma membrane fuse at
multiple sites in the anterior region of the sperm head and, as a
result, the acrosome content is released. Exocytosis of the sperm
acrosome –also called acrosome reaction – happens once in the
lifespan of the spermatozoa and is a prerequisite for sperm fusion
with the egg membrane.
Protein kinase C (PKC) has been proposed as a key component
of the acrosomal exocytosis transduction pathway; however, PKC
role in the process is not completely understood [2]. It has been
documented that phorbol esters, known PKC activators, trigger
acrosome exocytosis in different species [3–6], and that levels of
DAG, a natural agonist of PKC, increase when human sperm are
stimulated by progesterone or the calcium ionophore A23187 [7].
The mechanism of PKC participation in acrosomal exocytosis is
still unclear and much less is known about its potential targets.
Myristoylated alanine-rich C kinase substrate (MARCKS) is
known as the major cellular substrate for PKC in many cell types.
MARCKS has been implicated in the regulation of brain
development and postnatal survival, cellular migration and
adhesion, as well as phagocytosis, endocytosis, and exocytosis
[8]. The presence of MARCKS has been described previously in
rat testis by Western blot [9]. In this work, authors showed by
immunohistochemical studies that MARCKS appears equally
during all stages of spermatogenesis, except in mature spermato-
zoa [9]. Because of this, the expression of MARCKS in mature
sperm is unclear.
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MARCKS contains three highly conserved domains. The first
domain at the amino terminus contains the consensus sequence for
myristoylation and is responsible, together with the third domain,
for association of MARCKS with lipid membranes. The second
domain, also known as MH2 domain, resembles the cytoplasmic
tail of the cation-independent mannose-6-phosphate receptor but
its function is unknown. The third domain is referred to as the
effector domain (ED) or phosphorylation site domain and contains
four serine residues that can be phosphorylated by PKC. When
not phosphorylated, this domain can bind calmodulin with high
affinity, crosslink microfilaments of actin in vitro [10,11] or bind to
PIP2 [12]. ED phosphorylation results in loss of these activities,
and frequently is accompanied by translocation from the
membrane to the cytosol [8].
The aim of this study was to determine the expression of
MARCKS in human sperm and to describe its participation in
acrosomal exocytosis using two different and complementary
models: permeabilized and non-permeabilized sperm. Our results
show that MARCKS is present in human sperm and localizes to
the sperm head and the tail. In permeabilized cells, we report that
MARCKS has an inhibitory role in stimulated acrosomal
exocytosis and that this inhibitory function is abolished by
phosphorylation. In living sperm, using a permeable peptide
corresponding to MARCKS ED, we show that MARCKS also
inhibits exocytosis and, in addition, abrogates calcium mobiliza-
tion induced by progesterone. We also demonstrated that the level
of phosphorylated MARCKS increases during acrosomal exocy-
tosis activation by a natural inducer, such as progesterone, and
pharmacological activators, such as calcium ionophore and
phorbol ester. Our results show that MARCKS is a negative
modulator in acrosomal exocytosis, which is phosphorylated
during acrosomal exocytosis, and regulates calcium mobilization.
Materials and Methods
Ethics Statement
Human semen samples were obtained from normal healthy
donors. The participants provided their written informed consent
to participate in this study. The informed consent and protocol for
semen handling were carried out in accordance with the
Declaration of Helsinki (2008) and approved by the Ethic
Committee of the School of Medicine, Universidad Nacional de
Cuyo.
Reagents
Recombinant streptolysin O (SLO) was obtained from Dr.
Bhakdi (University of Mainz, Mainz, Germany). Protein kinase C
bII (PKC bII), Adenophostin A, 2-aminoethoxydiphenyl borate
(2-APB) and progesterone from Calbiochem were purchased from
Merck Quı´mica Argentina S.A.I.C. (Buenos Aires, Argentina).
Phosphatidylinositol 4, 5-bisphosphate (PIP2) was from Avanti
Polar Lipids, Inc., (Alabaster, USA). Prestained molecular weight
markers were from Bio Rad (Buenos Aires, Argentina). A goat
polyclonal anti-MARCKS antibody that recognizes the N-
terminus of human MARCKS (anti-MARCKS N-19) and
blocking peptide MARCKS N-19 were from Santa Cruz
Biotechnology, Inc. (Santa Cruz, CA). A mouse monoclonal
anti-MARCKS that recognizes the N-terminus corresponding to
amino acids 2–66 of human MARCKS (anti-MARCKS) and a
rabbit polyclonal anti-MARCKS that recognizes a peptide around
the serine 162 of MARCKS effector domain (anti-MARCKS ED)
were from Abcam. Rabbit polyclonal anti-phosphorylated
MARCKS (pSer152/156, anti-phospho-MARCKS) antibody, anti-
b-tubulin antibody, phorbol 12-myristate 13-acetate (PMA) and
fluorescein isothiocyanate-coupled Pisum sativum agglutinin (FITC-
PSA) were obtained from Sigma-Aldrich (Buenos Aires, Argen-
tina). A23187 was from Alomone Laboratories Ltd. (Jerusalem,
Israel). Cy3-labeled goat anti-rabbit antibody and DyLight488TM-
labeled donkey anti-mouse antibody were from Jackson Immuno-
chemicals (Sero-immuno Diagnostics, Inc. Tucker, GA). Strepta-
vidin-HRP and biotinylated secondary antibodies were purchased
from DAKO, Tecnolab (Buenos Aires, Argentina). Tetramethylr-
hodamine isothiocyanate- labeled Lens culinaris agglutinin (TRITC-
LCA) was from Vector Labs (Bioars, Argentina). Tetramethylrho-
damine-labeled human MARCKS peptide (ED-TMR) was from
Anaspec (USA). Glutathion-sepharose was from GE Healthcare
(Buenos Aires, Argentina). All other chemicals were purchased
from Sigma-Aldrich or Tecnolab (Buenos Aires, Argentina).
Site-directed mutagenesis of MARCKS effector domain
Plasmid encoding the effector domain of mouse MARCKS,
pGE3X-MARCKS (residues 96–184) fused to GST (wt MARCKS
ED) was kindly provided by Dr. Jae-Won Soh (University of Inha,
Incheon, Korea). MARCKS effector domain (ED) mutants were
prepared from pGEX-MARCKS plasmid using the Phusion site-
directed mutagenesis kit (New England Bio Labs). MARCKS ED
mutant carrying a Ser-to-Ala (MARCKS ED4A) or Ser-to-Asp
(MARCKS ED4D) substitutions at amino acid positions 152, 156,
159 and 163 were constructed by conventional PCR using the
following 59 in vitro phosphorylated mutagenic oligonucleotides: 59-
GAAGCGCTTT
GCCTTCAAGAAGGCCTTCAAGCTGGCCGGCTTCGC-
CTTCAAGAAGAGC -39 (MARCKS ED4A primer; forward)
and 59-GCGCTTTGACTTCAAGAAGGACTTC
AAGCTGGACGGCTTCGACTTCAAGCCG-39 (MARCKS
ED4D primer; forward). The reverse primer was 59-TTTT-
TTTTTTTCGGGGTCTCGCTGCTGGGCGACGG-39. Liga-
tion, transformation and analysis of transformants were performed
according to manufacturers instructions. Mutations were con-
firmed by sequencing.
Recombinant proteins
Plasmids encoding wild type MARCKS ED, the non-phosphor-
ylable MARCKS mutant (MARCKS ED4A), and the phospho-
mimetic MARCKS mutant (MARCKS ED4D) were transformed
in BL21 E. coli cells (Stratagene, La Jolla, CA, USA) and
expression was induced 3 h at 37uC with 0.5 mM isopropyl 1-thio-
D-galactopyranoside. Recombinant proteins were purified by
affinity chromatography on glutathione–sepharose beads following
standard procedures.
Acrosomal exocytosis assays
Acrosomal exocytosis assays were performed as previously
described [13]. Briefly, human semen obtained from normal
healthy donors was allowed to liquefy for 30-60 min at 37uC. We
used a swim-up protocol to isolate highly motile sperm under
capacitating conditions in Human Tubal Fluid media (HTF, as
formulated by Irvine Scientific, Santa Ana, CA) supplemented
with 0.5% bovine serum albumin (BSA) for 1 h at 37uC in an
atmosphere of 5% CO2/95% air. Sperm concentrations were
adjusted to 5–106106 cells/ml and incubated for at least 2 h
under capacitating conditions. We have shown previously that
human sperm incubated under these conditions are responsive to
progesterone [14]. The use of these incubation times permits a
direct comparison with our previous published results in
permeabilized [13,15–18] and non-permeabilized sperm [19,20].
Spermatozoa were used without permeabilization (living human
sperm) or permeabilized. In permeabilized sperm assays, sperma-
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tozoa were resuspended in cold phosphate buffered saline (PBS)
containing 2.1 U/ml SLO for 15 min at 4uC. Cells were washed
once with PBS and resuspended in ice-cold sucrose buffer
(250 mM sucrose, 0.5 mM EGTA, 20 mM Hepes-K, pH 7.4)
containing 2 mM dithiothreitol. For all acrosome exocytosis
assays, we added inhibitors and stimulants sequentially as
indicated in the figures, and incubated for 10–15 min at 37uC
after each addition. Sperm were spotted on teflon-printed slides,
air dried, and fixed/permeabilized in ice-cold methanol for 1 min.
Acrosomal status was evaluated by staining with FITC-coupled
Pisum sativum agglutinin (FITC-PSA) according to [21]. At least
200 cells were scored using a Nikon Optiphot II microscope
equipped with epifluorescence optics. Basal (no stimulation,
‘‘control’’) and positive (0.5 mM CaCl2, corresponding to 10 mM
free calcium, ‘‘Ca2+’’) controls were included in all experiments.
For each experiment, acrosomal exocytosis indexes were calculat-
ed by subtracting the number of reacted spermatozoa in the
negative control (range 10%–30%) from all values, and expressing
the resulting values as a percentage of the acrosome exocytosis
observed in the positive control (range 25%–40%). The average
difference between positive and negative controls was 12%
(experiments where the difference was less than 10% were
discarded). Data were evaluated using one-way ANOVA and post
hoc tests (Dunnett’s test or confident intervals). Differences were
considered significant at the p,0.05 level.
Preparation and addition of lipids to sperm
Lipids stocks were prepared and added as described previously
[22]. Briefly, 1 M PMA stock in DMSO was prepared and a N2
stream was applied before storing at 220uC.
We added 0.5 ml of the stock to 49.5 ml of DMSO to obtain a
0.01 M solution. From this stock we prepared additional dilutions
in sucrose buffer until getting a 10 mM PMA solution. One
microliter of the 10 mM stock was added to 49 ml of sperm
suspension to get a final concentration of 200 nM. Phosphatidy-
linositol–4, 5–bisphosphate (PIP2) was dissolved in chloroform:
methanol: water (20:9:1, v/v), vortexed and evaporated. The lipid
was then dissolved in chloroform and dried under a nitrogen
stream. PIP2 micelles were made by suspending the lipid in sucrose
buffer at a final concentration of 2.5 mM (stock solution), followed
by several minutes of sonication at maximum power. One
microliter of the 2.5 mM solution was added to 49 ml of sperm
suspension in sucrose buffer to get a final concentration of 50 mM
PIP2.
SDS-PAGE and Western blots
To examine the presence of MARCKS and phosphorylated
MARCKS, the fraction of motile sperm capacitated for 2–3 h in
BSA supplemented-HTF medium was used. After removing the
HTF by washing cells twice with cold PBS, sperm pellets were
resuspended in sample buffer (2% SDS, 10% glycerol, and
62.5 mM Tris-HCl pH 6.8) without disulfide reducing agents.
Proteins were extracted by heating three times to 95uC for 4 min
each. Extracts were centrifuged (12,0006g) for 10 min, and the
supernatants were adjusted to 5% b-mercaptoethanol. Protein
were resolved on 10% polyacrylamide gels according to [23], and
transferred to PVDF membranes (Millipore). Non-specific reac-
tivity was blocked by incubation for 1 h at room temperature (RT)
with 5% skim milk dissolved in tris-buffered saline with 0.1%
Tween-20 (T-TBS: 50 mM Tris-HCl pH 7.4, 150 mM NaCl,
0.1% Tween-20). Blots were incubated with primary anti-
MARCKS antibody from Abcam (0.26 mg/ml), anti-MARCKS
N-19 from Santa Cruz (0.13 mg/ml), or anti-phospho-MARCKS
(0.06 mg/ml), in blocking solution overnight at 4uC. Biotinylated,
goat anti-mouse-IgG (0.076 mg/ml), biotinylated, rabbit anti-goat-
IgG (0.4 mg/ml) or biotinylated, goat anti-rabbit-IgG (0.076 mg/
ml) were used as secondary antibodies during 60 min incubations
at RT. Blots were then incubated with peroxidase-conjugated
streptavidin (0.17 mg/ml) during 60 min incubations at RT.
Excess first and second antibodies, and peroxidase-conjugated
streptavidin were removed by washing five times for 10 min each
in T-TBS. For loading control blots were reprobed with anti-b-
tubulin. Detection was accomplished with an enhanced chemilu-
minescence system (ECL; GE Healthcare) and visualized with a
Fujifilm LAS-4000 Scanner (Fujifilm, Tokyo, Japan).
In vitro phosphorylation assays
15 mM MARCKS ED domains were incubated in 20 mM
HEPES-K pH 7.4, 2 mM DTT, 100 mM ATP, 5 mM MgCl2,
containing 0.6 U/ml of PKC bII, 140 mM phosphatidylserine,
325 nM PMA, and 100 mM CaCl2 for 40 min at 37uC. After
incubation, the mixtures were filtered through a Sephadex G-25
spin column equilibrated with sucrose buffer to eliminate PMA
and small molecules. Filtered mixtures were kept at 270uC until
use. For 32P-labelling of the recombinant proteins, 5 mM
MARCKS ED, MARCKS ED4A, MARCKS ED4D, and GST
were incubated with PKC bII as described above with the addition
of protease inhibitors (0.6 mM PMSF and 1 mM leupeptin). The
ATP concentration was reduced to 10 mM containing 5 mCi/ml
[c32P] ATP (NEN PerkinElmer, Migliore Laclaustra, Argentina).
Proteins were resolved in 10% Tris-glycine SDS-PAGE gels. The
gels were dried and exposed to Pierce CL-XPosure Film
(Tecnolab, Argentina).
Indirect immunofluorescence
Capacitated sperm were adjusted to 76106 cells/ml, spotted on
poly-L-lysine-coated slides, and fixed in 2% paraformaldehyde in
PBS for 10 min at RT. After fixation, sperm were incubated in
50 mM glycine–PBS for 10 min at RT and permeabilized with
0.1% Triton X-100 for 10 min. Non-specific reactivity was
blocked for 1 h in 5% BSA in PBS. Cells were labeled with
anti-MARCKS antibody (overnight at 4uC, 135 nM in 2% BSA)
followed by a DyLight488-labeled anti-mouse IgG (1 h at RT,
3 mg/ml in PBS containing polyvinylpyrrolidone, PBS/PVP) or
anti-phospho-MARCKS (overnight at 4uC, 135 nM in 2% BSA)
followed by a Cy3-labeled anti-rabbit IgG (1 h at RT, 3 mg/ml in
PBS/PVP). In some experiments, the anti-phospho-MARCKS
antibody was preincubated with phosphorylated MARCKS-ED
domain (1.35 mM). Cover slips were washed with 0.1% PVP in
PBS between incubations. Finally, the cells were incubated 1 min
in cold methanol, and stained with FITC-PSA or TRITC-LCA for
40 min at RT, and washed with PBS/PVP. Cover slips were
mounted in 1% Vectashield (Vector Labs). Sperm cells were
analyzed by fluorescence microscopy using an Olympus Confocal
FV1000 and processed with the program FV10-ASW1.7.
Intracellular calcium measurements of human
spermatozoa
Calcium levels were measured in sperm suspensions using the
intracellular fluorescent probe Fluo-3-AM. Motile sperm were
adjusted to a concentration of 5–10 6106 cells/ml and loaded
with the permeable form of the dye (Fluo-3-AM, 2 mM) for 30 min
at 37uC. Cells were washed once and resuspended in HTF. Sperm
suspensions were transferred to thermostated (37uC) cuvettes for
fluorescence measurements and stirred constantly. At the indicated
times, 15 mM progesterone was added to the samples. When
indicated, sperm where incubated 30 min in presence of 4 mM of
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the permeable tetramethylrhodamine-labeled MARCKS ED (ED-
TMR) before adding progesterone. Fluo-3 fluorescence
(lEx = 505 nm, lEm = 525 nm emission) was recorded in an
AMINCO-Bowman Series 2 (AB2) spectrofluorometer. Data were
collected during 600 seconds at a frequency of 0.5 Hz. To
calibrate the maximal response, intracellular calcium concentra-
tion ([Ca2+]i) was determined using Triton X-100 (0.1%).
Measurements were performed at least three times with different
batches of sperm. The criterion we used for inclusion of the results
obtained with a given sample into the statistical analysis was the
normal response to 15 mM progesterone.
Results and Discussion
MARCKS is expressed in human spermatozoa
The acrosomal exocytosis is a regulated exocytosis in which the
outer membrane of the acrosome and the plasma membrane fuse
in the anterior region of the sperm head. Fusion at multiple sites
between these membranes causes the release of the acrosomal
contents and the loss of the membranes surrounding the acrosome.
This particular exocytosis is a synchronized and tightly regulated
process, with no recycling of membranes. In the last few years, we
have shown that acrosomal exocytosis is mediated by a molecular
mechanism that is homologous to that reported for secretion in
neuroendocrinal cells [24].
MARCKS has been implicated in neurosecretion and exocy-
tosis [25–28]; nevertheless the precise molecular mechanism of
MARCKS in exocytosis is not well known and it is unknown if it
participates in the signal transduction pathway of acrosomal
exocytosis. The presence of MARCKS in human sperm is still
unclear. Mosevitsky and Silicheva have reported that MARCKS is
present in all stages of spermatogenesis in rat testis; however, they
did not find MARCKS in mature spermatozoa [9,29]. This
prompted us, first, to determine the presence of MARCKS in
human sperm by Western blot. The theoretical molecular mass of
MARCKS is 32 kDa; however on SDS-PAGE, MARCKS shows
an anomalous migration corresponding to a 80 kDa protein due to
its non-globular, elongated forms and the weak binding of SDS
molecules to the highly acidic amino acids [8]. Proteins from
mouse brain and whole human sperm extracts were resolved by
SDS-PAGE, transferred to PVDF membranes and probed with
antibodies raised against either the N-terminal domain (anti-
MARCKS and anti-MARCKS N-19, see Materials and Methods
for more details) or the effector domain of phosphorylated
MARCKS (anti-phospho-MARCKS). Using the anti-MARCKS
antibody, immunoblot analysis of whole cell extracts from human
sperm demonstrated the presence of a single protein band
comigrating with mouse brain MARCKS. The apparent molec-
ular mass of MARCKS was 73 kDa, suggesting that a related, if
not identical, form is present in these cells (Fig. 1A). Similar results
were obtained when a different antibody raised against the N-
terminal domain of MARCKS (anti-MARCKS N-19) was assayed
(Fig. S1A). Preincubation with an excess of a blocking peptide
corresponding to the N-terminal domain of MARCKS reduced
the signal substantially, indicating that antibodies were specific
(Fig. S1A). Human sperm samples were also probed with a
polyclonal antibody raised against a synthetic phosphorylated
peptide derived from the region of rat MARCKS that is
phosphorylated on serines 152 and 156 (anti-phospho-MARCKS
antibody). As shown in Fig. 1B, the antibody recognized a single
band of the expected molecular weight (73 kDa).
Next, using the same antibodies, indirect immunostaining was
used to localize MARCKS on fixed sperm. MARCKS localized to
the head and the tail of human sperm. The N-terminal MARCKS
antibodies showed a punctuate pattern in acrosomal region and a
homogenous pattern in the postacrosomal region in 98% of
acrosome intact cells (Fig. 1C and S1B). It is important to point out
that this punctate pattern of MARCKS has been previously
described in other cells such as neurons [30]. The phospho-
MARCKS antibody showed a uniform pattern in the acrosomal
region without staining in the postacrosomal region of the sperm
head in 89% of acrosome intact cells (Fig. 1D and S1C). All
antibodies showed a uniform labeling in the tail of all cells
evaluated. The preincubation of anti-phospho-MARCKS anti-
body with an in vitro phosphorylated recombinant MARCKS
peptide abolished the signal of phospho-MARCKS in the
acrosomal region and the tail, indicating that staining was specific.
Blocking experiments also showed that label on the midpiece of
the flagellum was unspecific (Fig. S1C). Altogether, these results
indicate that both phosphorylated and non-phosphorylated
MARCKS proteins are present in capacitated human spermato-
zoa and localize to the head and the tail.
MARCKS participates in acrosomal exocytosis in human
sperm
To investigate whether MARCKS plays a role in acrosomal
exocytosis in human sperm, we attempted to inhibit the function of
the endogenous protein by treating permeabilized cells with
different antibodies raised against main domains involved in
MARCKS function: the N-terminal domain and the effector
domain.
We first tested antibodies against the N-terminal domain.
Permeabilized sperm were incubated with increasing concentra-
tions of the antibody raised against the N-terminus, anti-
MARCKS N-19 antibody, prior to addition of calcium or phorbol
12-myristate 13-acetate (PMA), a permeable analog of DAG. As
shown in Fig. 2A (white symbols), the antibody abrogated the
acrosomal exocytosis stimulated by both activators. When
stimulated with calcium, the half maximal inhibitory concentra-
tion (IC50, mean6SEM) for anti-MARCKS N-19 antibody was
1563 nM. When stimulated with PMA, the IC50 was 762 nM.
The inhibitory effect of the anti-MARCKS N-19 antibody was
blocked when the antibody was preincubated with the blocking
peptide N-19 (Fig. 2B). Similar results were obtained when the
other anti-MARCKS antibody raised against the N-terminal
domain, anti-MARCKS, was assayed (data not shown). The
addition of a non-immune goat antibody had no effect (data not
shown). These results indicate that the inhibitory effect of the
antibodies was specific. In conclusion, we found that preincubation
of cells with antibodies against the N-terminal domain of
MARCKS blocks acrosomal exocytosis. Little is known about
the function of the N-terminal domain of MARCKS and its
participation in membrane fusion. Singer and collaborators have
reported that MARCKS is attached to membranes of intracellular
mucin granules and that this association is inhibited by a peptide
corresponding to the MARCKS N-terminal domain [31]. Takashi
and collaborators published that the same peptide inhibited
degranulation of human leukocytes in vitro [32]. Nevertheless, the
mechanism of the N-terminal domain of MARCKS in these
secretory processes is not fully understood.
MARCKS effector domain is considered the responsible
domain for most of the function of MARCKS, however the
mechanism is still unclear [8]. To investigate the participation of
MARCKS effector domain in acrosomal exocytosis, we assayed an
antibody raised against this domain (anti-MARCKS ED).
Permeabilized sperm were incubated with increasing concentra-
tions of this antibody prior to addition of calcium or PMA. As
shown in Fig. 2A (gray symbols), the antibody abolished the
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acrosomal exocytosis stimulated by both activators. When
stimulated with calcium, the IC50 for anti-MARCKS ED antibody
was 763 nM. When stimulated with PMA, the IC50 was 762 nM.
The inhibitory effect of the anti-MARCKS ED antibody was
blocked when the antibody was preincubated with the recombi-
nant MARCKS ED peptide (Fig. 2B). The addition of a non-
immune rabbit antibody showed no effect (data not shown). These
results indicate that the inhibitory effect of the anti-MARCK ED
antibody might be the result of binding to the effector domain of
endogenous MARCKS, perturbing its function in acrosomal
exocytosis.
Finally, we assayed increasing concentrations of the anti-
phospho-MARCKS antibody in the calcium- and PMA-triggered
acrosomal exocytosis. Surprisingly, this antibody had not effect on
stimulated exocytosis and concentrations up to 33 nM of anti-
phospho-MARCKS antibody showed no inhibition (Fig. 2A, black
symbols). Prior studies indicate that MARCKS phosphorylation
abrogates membrane binding of MARCKS in many cell types,
because neutralization of the positive charges of the basic residues
by the phosphoserine residues abolishes the electrostatic contri-
bution of the MARCKS effector domain to membrane binding
[8]. Therefore, phosphorylated MARCKS is considered the
inactive form of MARCKS [33]. The finding that a phospho-
MARCKS antibody was unable to inhibit acrosomal exocytosis is
consistent with the idea that phosphorylated MARCKS is inactive
in our model when human sperm are stimulated by calcium or
PMA.
So far, our results show that MARCKS participates in
acrosomal exocytosis, and this participation may be mediated by
the N-terminal domain and the non-phosphorylated effector
domain.
The inhibitory role of MARCKS is abolished by
phosphorylation
MARCKS functions in exocytosis are associated mainly with
the MARCKS effector domain. Studies in a variety of isolated or
cultured cell types indicate that the phosphorylation state of
MARCKS effector domain controls its function. Our results
showed that anti-phospho-MARCKS antibody did not affect
acrosomal exocytosis whereas the anti-MARCKS ED antibody
abolished secretion (Fig. 2). These results suggested that phos-
phorylated MARCKS ED does not interact with the endogenous
machinery in acrosomal exocytosis and raised the question
whether non-phosphorylated MARCKS ED does. To test this
hypothesis wild type (wt) MARCKS ED was expressed in bacteria
as GST fusion protein. After purification, wild type MARCKS ED
was incubated under phosphorylating conditions before challeng-
ing the acrosome exocytosis (see Materials and Methods and
Fig. 3B). Both, non-phosphorylated MARCKS ED and in vitro
phosphorylated MARCKS ED were tested in the permeabilized
sperm acrosomal exocytosis assay stimulated by calcium and
PMA. Non-phosphorylated MARCKS ED was able to abrogate
secretion (Fig. 3C; IC50, 0.5560.05 mM). On the contrary,
phosphorylated MARCKS ED did not abolish stimulated
Figure 1. MARCKS is expressed in human sperm. (A) Proteins from whole sperm homogenates (sperm, 56106 cells) were resolved in 10% SDS-
PAGE gels and immunoblotted with the anti-MARCKS antibody raised against the N-terminus of MARCKS. Brain extracts (brain) was used as a positive
control. (B) Identical to A but immunoblotted with the anti-phospho-MARCKS antibody. (C) Sperm were double-stained with the anti-MARCKS
antibody followed by an anti-mouse-DyLight488-conjugated antibody and with tetramethylrhodamine isothiocyanate-labeled Lens culinaris
agglutinin to stain acrosomes (TRITC-LCA). (D) Sperm were double-stained with the anti-phospho-MARCKS antibody followed by an anti-rabbit-Cy3
antibody and FITC-coupled Pisum sativum agglutinin to stain acrosomes (FITC-PSA). Shown are representative images from three different
experiments. DIC, cells observed with differential interference contrast. Bars = 5 mm
doi:10.1371/journal.pone.0064551.g001
Role of MARCKS in Human Acrosomal Exocytosis
PLOS ONE | www.plosone.org 5 May 2013 | Volume 8 | Issue 5 | e64551
acrosomal exocytosis (Fig. 3C). To eliminate the possibility that the
observed results were the consequence of a differential diffusion
into permeabilized sperm of phosphorylated and non-phosphor-
ylated MARCKS ED peptide, indirect immunofluorescence
against GST was performed. Both, phospho- and non-phosphor-
ylated peptides diffused equally into permeabilized cells (Figure
S2). Our results indicated that only non-phosphorylated
MARCKS ED interacts with the fusion machinery operating
during acrosomal exocytosis.
To further confirm these results, we generated two different
mutants of MARCKS ED: the constitutively non-phosphorylable
and the constitutively phosphorylated MARCKS (or phosphomi-
metic) by replacement the 4 serines in the ED with alanine
(MARCKS ED4A) and aspartic acid (MARCKS ED4D), respec-
tively (see mutants scheme in Fig. 3A). These mutants were
expressed in bacteria as GST-fusion proteins and purified on
glutathione-sepharose columns. When these mutants were assayed
in acrosome exocytosis, only the MARCKS ED4A mutant
inhibited the exocytosis stimulated by calcium and PMA
(Fig. 3D; IC50, 0.560.07 mM) with similar potency than the
recombinant non-phosphorylated peptide (compare Fig. 3C and
3D). None of the mutants incorporated c32P ATP in the presence
of PKC bII, indicating that these recombinant proteins cannot be
phosphorylated (Fig. 3B). The diffusion of MARCKS mutants into
permeabilized sperm was also analyzed by indirect immunofluo-
rescence against GST. Both MARCKS ED4A and MARCKS
ED4D mutants diffused similarly into permeabilized sperm (Fig
S2).
These results are consistent with observations in others secretory
cells. A peptide of the MARCKS ED inhibited the PMA-induced
norepinephrine release in permeabilized parotid acinar cells
[34,35]. In bovine luteal cells expressing a mutant MARCKS
that cannot be phosphorylated by PKC, prostaglandin F2a failed
to stimulate oxytocin exocytosis [36]. Our findings indicate that
MARCKS is a component of the signal transduction pathways in
acrosomal exocytosis and that its inhibitory role is regulated by
phosphorylation.
The inhibitory role of MARCKS is reverted by PIP2 and
adenophostin
We found that wt MARCKS ED or mutant MARCKS ED4A
inhibited stimulated acrosomal exocytosis and we wondered about
the mechanism of the inhibition of these domains. Heo and
collaborators [37] found that MARCKS ED binds to the plasma
membrane through its association with phosphoinositides, mainly
with phosphatidylinositol 4, 5-bisphosphate (PIP2) and, because of
this, MARCKS has been called pipmodulin [12,38]. Therefore we
proposed that the functional effects we observe in this study are
due to PIP2 sequestration by wt MARCKS ED or mutant
MARCKS ED4A domains. Although regulation of the principal
enzymes involved in PIP2 synthesis and degradation can contrib-
ute to local modulation of PIP2 levels in some cases, McLaughlin
and collaborators [38] have postulated that synthesis alone is
insufficient to maintain lateral concentration gradients of a
relatively abundant lipid in the face of diffusion, and that
additional mechanisms such as lateral sequestration and local
release must also be involved in spatiotemporal control of PIP2.
Our group has previously proposed that PIP2 is continuously
produced in a positive loop in human sperm [22]. We hypothesize
that MARCKS acts as a pipmodulin in acrosomal exocytosis and
that the addition of PIP2 would recover acrosomal exocytosis
inhibited by MARCKS ED in human sperm. In fact, as shown in
Fig. 4, PIP2 was able to recover the MARCKS ED inhibition in
Figure 2. MARCKS participates in acrosomal exocytosis. (A)
Permeabilized sperm were incubated for 15 minutes at 37uC in the
presence of increasing concentrations of anti-MARCKS N-19 antibody
(anti-M, white symbols), anti-MARCKS ED (anti-ED, gray symbols) and
anti-phospho-MARCKS (anti-pM, black symbols). Acrosomal exocytosis
was initiated by adding 10 mM free Ca2+ (circles) or 200 nM PMA
(squares). For all conditions, the incubation continued for an additional
15 minutes and acrosomes were evaluated by lectin binding. (B)
Permeabilized sperm were incubated for 15 minutes at 37uC in the
presence of 33 nM anti-MARCKS N-19 antibody (anti-M) preincubated
with an excess (1: 10) of blocking peptide MARCKS N-19 (anti-M+pep)
and in the presence of 33 nM anti-MARCKS ED antibody (anti-ED)
preincubated with an excess (1:10) of MARCKS effector domain (anti-
ED+ED). Acrosomal exocytosis was then initiated by adding 10 mM free
Ca2+ or 200 nM PMA and the incubation continued for an additional 15
minutes (black bar). Control experimental conditions (gray bars) include
background acrosomal exocytosis in the absence of any stimulation
(control), acrosomal exocytosis stimulated by 10 mM free Ca2+ (Ca2+)
and by 200 nM PMA (PMA) and the effect of antibodies without peptide
preincubation anti-MARCKS N-19 (anti-M) and anti-MARCKS ED (anti-
ED). The percentage of reacted sperm was normalized as described in
Materials and Methods. The data represent the means6SEM of at least
three independent experiments. The asterisks indicate significant
differences from similar conditions stimulated with Ca2+ (**, p,0.01;
*, p, 0.05); n/s, not significant difference.
doi:10.1371/journal.pone.0064551.g002
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acrosomal exocytosis stimulated by calcium (Fig. 4A) and by PMA
(Fig. 4B).
PIP2 generates the second messengers, inositol 1, 4, 5-
triphosphate (IP3) and diacylglycerol (DAG). An increase on IP3
level would activate IP3-sensitive calcium channels allowing the
efflux of this ion from intracellular stores (most likely the
acrosome). Hence, we hypothesize that signaling through
MARCKS regulates the intracellular calcium mobilization
required for the acrosomal exocytosis. If this was the case, then,
MARCKS ED (Fig. 3C) and MARCKS ED4A (Fig. 3D) would
block exocytosis because they prevented calcium mobilization. We
tested this possibility by promoting intravesicular calcium release
with the IP3-sensitive calcium channel agonist adenophostin. The
sole addition of adenophostin rescued exocytosis impaired by
MARCKS ED (Fig. 4C and 4D), supporting the notion that the
end point of the MARCKS pathway is the mobilization of
intracellular calcium.
Our results indicate that both PIP2 and adenophostin are able
to reverse the inhibitory effect of non-phosphorylated MARCKS
in stimulated acrosomal exocytosis.
These findings suggest that MARCKS inhibits secretion by
sequestering PIP2 and preventing the release of calcium through
IP3-sensitive calcium channels.
Assessing MARCKS function on acrosomal exocytosis in
non-permeabilized sperm
So far all results were obtained using the SLO-permeabilized
human sperm model. Our group has previously showed that
polybasic amino acids-containing proteins can penetrate the sperm
plasma membrane and thus are valuable tools to study sperm
physiology in intact cells [19]. Fortunately, MARCKS ED meets
this requirement and it can be assayed in acrosomal exocytosis in
non-permeabilized sperm. To investigate the function of
MARCKS in intact cells, we analyzed the effect of a permeable
peptide corresponding to wt MARCKS ED in living human
sperm. We used a commercial MARCKS peptide, the tetra-
methylrhodamine-conjugated peptide sequence
KKRFSFKKSFKL (ED-TMR) derived from amino acid residues
Figure 3. MARCKS inhibits acrosomal exocytosis and this effect
is dependent on phosphorylation. (A) Amino acid sequence
(residues 145–169) of mouse wild type MARCKS effector domain (ED),
the non-phosphorylable MARCKS ED mutant (ED4A), the phosphomi-
metic MARCKS ED mutant (ED4D), and permeable tetramethylrhoda-
mine-conjugated MARCKS ED peptide (ED-TMR). (B) Purified GST fusion
proteins of wild type MARCKS ED (ED), MARCKS ED4A mutant (ED4A),
MARCKS ED4D (ED4D), and GST (26 kDa) were incubated for 40 minutes
at 37uC with (+) or without (-) PKC bII under activating conditions in the
presence of [c32P]ATP. Samples were then resolved by 10% SDS-PAGE
gels, and radiolabeled proteins were detected by autoradiography.
Shown is a representative gel from three independent experiments. (C)
Permeabilized sperm were treated for 15 minutes at 37uC with
increasing concentrations of MARCKS effector domain (ED, white
symbols) or in vitro phosphorylated MARCKS ED (pED, black symbols).
Acrosomal exocytosis was initiated by adding 10 mM free Ca2+ (circles)
or 200 nM PMA (squares). In all conditions, the incubation continued for
an additional 15 minutes and acrosomal exocytosis was evaluated by
lectin binding. (D) Permeabilized sperm were treated for 15 minutes at
37uC with increasing concentrations of MARCKS ED4A (ED4A, white
symbols) or MARCKS ED4D (ED4D, black symbols). Acrosomal exocy-
tosis was initiated by adding 10 mM free Ca2+ (circles) or 200 nM PMA
(squares). In all conditions the incubation continued for an additional 15
minutes and acrosomal exocytosis was evaluated by lectin binding. In C
and D, the percentage of reacted sperm was normalized as described in
Material and Methods. The data represent the means6SEM of at least
three independent experiments. The asterisks indicate significant
differences from similar conditions stimulated with Ca2+ (*, p,0.05;
**, p,0.01; ***, p,0.001).
doi:10.1371/journal.pone.0064551.g003
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154 –165 of human MARCKS ED, which retains the first two of
the four serine residues in the ED (see peptide scheme in Fig. 3A).
First, we determined the permeability of ED-TMR in living
human sperm (see Fig. S3). To rule out that the translocation of
the protein was a fixation artifact, cells were treated with trypsin
before fixation. Under this condition, permeable ED-TMR
peptide was detected mainly in the head of human sperm (Fig.
S3). A similar permeable MARCKS peptide has been used in sea
urchin sperm and it was found enriched in the acrosome region
[39].
Then, we tested the permeable TMR-labeled peptide in the
acrosomal exocytosis assay using non-permeabilized sperm. We
found that ED-TMR inhibited the secretion stimulated by calcium
ionophore A23187, PMA, and progesterone in a concentration-
dependent manner in human sperm (Fig. 5A). Note that the
permeable peptide results in intact sperm are similar to those
obtained with the recombinant wt MARCKS ED and mutant
MARCKS ED4A in permeabilized cells (compare Fig. 5A and
Fig. 3C and 3D). It is interesting to note that the acrosomal
exocytosis index in the presence of high concentrations of ED-
TMR (Fig. 5A), wt MARCKS ED (Fig. 3C), and MARCKS
ED4A (Fig. 3D) was significantly lower than the index in
unstimulated controls. This indicates that the compounds are
inhibiting basal acrosome exocytosis. It has been shown that
unphosphorylated MARCKS effector domain crosslinks F-actin in
vitro [40]. We think that the addition of MARCKS ED and
MARCKS ED4A in permeabilized cells, and ED-TMR in non-
permeabilized cells, might be crosslinking F-actin in human sperm
and stabilizing the actin cytoskeleton underneath the plasma
membrane and, consequently, inhibiting spontaneous acrosome
exocytosis. Nevertheless, further studies are needed to elucidate
this observation.
To test the hypothesis that MARCKS was involved in calcium
mobilization, we measured intracellular calcium levels in human
spermatozoa preincubated with the ED-TMR peptide and
stimulated with progesterone. Progesterone stimulates a rapid,
extracellular calcium-dependent, transient increase in human
sperm ([Ca2+]i) necessary for initiation of the acrosomal exocytosis
[41–43]. When intact human sperm were preincubated with ED-
TMR peptide, the increase in calcium levels caused by proges-
Figure 4. PIP2 and adenophostin rescue inhibition of MARCKS effector domain in acrosomal exocytosis. Permeabilized sperm were
treated for 15 minutes at 37uC with 1 mM MARCKS effector domain (ED); then, 50 mM PIP2 was added for another 15 min and acrosomal exocytosis
was initiated by adding 10 mM free Ca2+ (A) or 200 nM PMA (B). The incubation continued for an additional 15 minutes (black bars). Control
experimental conditions (gray bars) include background acrosomal exocytosis in the absence of any stimulation (control), acrosomal exocytosis
stimulated by 10 mM free Ca2+ (Ca2+) and by 200 nM PMA (PMA), the absence of effect of PIP2 with or without acrosomal exocytosis stimulation.
Permeabilized sperm were treated for 15 minutes at 37uC with 1 mM MARCKS effector domain (ED); then, 5 mM adenophostin was added (Ad), and
acrosomal exocytosis was initiated by adding 10 mM free Ca2+ (C) or 200 nM PMA (D). The incubation continued for an additional 15 minutes (black
bars). Control experimental conditions (gray bars) include background acrosomal exocytosis in the absence of any stimulation (control), acrosomal
exocytosis stimulated by 10 mM free Ca2+ (Ca2+) and by 200 nM PMA (PMA), the absence of effect of adenophostin with or without acrosomal
exocytosis stimulation, and the inhibitory effect of ED in acrosomal exocytosis. The percentage of reacted sperm was normalized as described in
Materials and Methods. The data represent the means6SEM of at least three independent experiments. The asterisks indicate significant differences
from similar conditions without PIP2 or adenophostin (**, p,0.01; ***, p,0.001).
doi:10.1371/journal.pone.0064551.g004
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terone (Fig. 5B) was significantly diminished (Fig. 5C and 5D).
Interestingly, these results are similar with those obtained in mast
cells, in which a constitutively non-phosphorylable MARCKS
mutant inhibited calcium mobilization and degranulation [44].
Our findings validate the hypothesis that MARCKS regulates
calcium mobilization in living human sperm.
So far these results show that non-phosphorylated MARCKS
inhibited acrosomal exocytosis when stimulated by different
activators in both permeabilized and living human sperm. In fact,
in SLO-permeabilized spermatozoa, both the recombinant wt
MARCKS peptide and a non-phosphorylable MARCKS mutant
inhibited exocytosis activated by calcium and PMA (Fig. 3C and
3D, white symbols). In non-permeabilized spermatozoa, a
permeable peptide corresponding to the MARCKS effector
domain inhibited exocytosis triggered by calcium ionophore
A23187, PMA, and progesterone (Fig. 5A). On the contrary,
when phosphorylated forms of MARCKS - in vitro phosphorylated
domain or phosphomimetic MARCKS mutant - were tested in the
acrosomal exocytosis assay, they were unable to abrogate
exocytosis (Fig. 3C and 3D, black symbols). These results suggest
that MARCKS might be inactivated by phosphorylation during
acrosomal exocytosis and we tested this hypothesis. We investi-
gated whether MARCKS was phosphorylated during the activa-
tion of exocytosis by different stimulators. Human sperm were
incubated with 2-aminoethoxy diphenyl borate (2-APB) before
stimulation. 2-APB is an IP3-sensitive calcium channel inhibitor,
which arrests acrosomal exocytosis when outer acrosomal and
plasma membranes are in close apposition [45]. Hence, 2-APB
avoids the formation of hybrid vesicles preventing the loss of
membranes and membrane-associated proteins that would occur
during the acrosomal exocytosis. As shown in Fig. 5E and 5F,
phosphorylated MARCKS increased significantly when acrosomal
exocytosis was stimulated by calcium ionophore A23187, PMA,
and progesterone (50%, 60%, and 40%, respectively). These
percentages were obtained when data were normalized against ß-
tubulin as loading control (Fig. 5F). When data were normalized
against MARCKS, similar results were obtained (see Fig. 5G and
5H for the effect of A23187; the results for PMA and progesterone
are not shown). These results indicate that the level of phospho-
MARCKS increases during acrosomal exocytosis, whereas total
MARCKS levels remain constant.
Figure 5. Assessing MARCKS function on acrosomal exocytosis in non-permeabilized sperm. (A) Capacitated and non-permeabilized
sperm were treated for 30 minutes at 37uC with increasing concentrations of a permeable tetramethylrhodamine-labeled MARCKS ED peptide (ED-
TMR). Acrosomal exocytosis was then initiated by adding 10 mM calcium ionophore A23187 (circles), 200 nM PMA (squares) or 15 mM progesterone
(triangles), and the incubation continued for 15 minutes. The percentage of reacted sperm was normalized as described in Materials and Methods.
The data represent the means6SEM of at least three independent experiments. The asterisks indicate significant differences from similar conditions
without ED-TMR (*, p,0.05; **, p,0.01; ***, p,0.001). (B) Capacitated and non-permeabilized sperm were loaded with 2 mM Fluo-3-AM and
incubated for 30 min at 37uC. At the indicated time (arrow) 15 mM progesterone was added. Maximal [Ca2+]i response was calibrated with 0.1% Triton
X-100 (TX-100, arrow) at the end of the incubation period. Shown are traces representative of three experiments. The increase in fluorescence is
expressed as (F/F0)-1 ((maximum fluorescence intensity/initial fluorescence)-1) versus time in seconds. (C) Identical to B with previous incubation for
30 min with 4 mM ED-TMR, before adding progesterone (arrow). (D) Quantification of three independent experiments. Bars represent mean6SEM;
data were normalized to the calcium response to progesterone in the absence of ED-TMR. The asterisk indicates a significant difference from
stimulation with progesterone (*, p,0.05; Student’s t test). (E) Non-permeabilized and capacitated sperm were incubated for 15 min at 37uC with
100 mM 2-APB (control) and then treated for 20 min with 10 mM A23183, 200 nM PMA, or 15 mM progesterone. After treatment, proteins of each
condition (56106 cells) were resolved in a 10% gels and transferred to PVDF membranes. Phosphorylated MARCKS was detected by Western blot
assay using an anti-phospho-MARCKS antibody. Anti-b-tubulin antibody was used as loading control. (F) Quantification of three independent
experiments showed in E. Bars represent mean6SEM; data were normalized against b-tubulin signal in control sperm. The asterisks indicate a
significant difference from control sperm (*, p,0.05; **, p,0.01). (G) Capacitated and non-permeabilized sperm were incubated for 15 min at 37uC
with 100 mM 2-APB (control) and then treated for 20 min with 10 mM A23183. After treatment, proteins of each condition (56106 cells) were resolved
in a 10% gels and transferred to PVDF membranes. Phosphorylated MARCKS was detected by Western blot assay using an anti-phospho-MARCKS
antibody. Anti-MARCKS antibody was used as loading control. (H) Quantification of three independent experiments showed in G. Bars represent
mean6SEM; data were normalized against MARCKS signal in control sperm. Asterisk indicates a significant difference from control sperm (*, p,0.05).
doi:10.1371/journal.pone.0064551.g005
Figure 6. Working model for the role of MARCKS in acrosomal exocytosis. In resting sperm, MARCKS is present in two forms, a
phosphorylated form in cytosol and another non-phosphorylated form, which binds to membranes sequestering PIP2 (1). When sperm is activated by
a natural inducer such as progesterone, acrosomal exocytosis is triggered by a cytoplasmic increase of Ca2+ (2). Then, Ca2+ and DAG activate
conventional PKC. Activated PKC phosphorylates the effector domain of MARCKS. Phosphorylated MARCKS is translocated to cytosol, augmenting
the availability of PIP2 (3). PIP2 is hydrolyzed by PLC to generate IP3 and DAG. IP3 elicits the efflux of Ca
2+ from acrosome (4). In addition, PIP2 interacts
with SNAREs proteins and synaptotagmin (Stg) to fuse plasma and outer acrosomal membranes (5). Stx, syntaxin; VAMP, vesicle associated
membrane protein; SNAP-25, synaptosomal-associated protein 25.
doi:10.1371/journal.pone.0064551.g006
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The fact that MARCKS is phosphorylated by different
activators during acrosomal exocytosis is compatible with the idea
that, in human sperm, non-phosphorylated MARCKS is released
from membranes by phosphorylation, increasing the availability of
PIP2 to generate IP3. In addition, PIP2 might also interact with
proteins involved in membrane fusion such as SNARE and
synaptotagmin. A variety of SNARE proteins are expressed in
human sperm, including syntaxins 1A, 1B, 4, and 6, SNAP-23 and
SNAP-25, and VAMP-2 [46], and studies in other cell types have
provided evidence for a role for PIP2 in regulating syntaxin-1 and
VAMP-2–mediated membrane fusion [47]. Synaptotagmins are a
family of Ca2+ sensor proteins that participate in multiple
exocytotic pathways, including acrosomal exocytosis [15]. Simi-
larly to MARCKS, the binding of synaptotagmin to phospholipids
is also regulated by phosphorylation [48].
In summary, we report the expression of MARCKS in human
sperm and its participation in the signal transduction pathway of
acrosomal exocytosis. In SLO-permeabilized sperm, we demon-
strate that MARCKS inhibits secretion and that this inhibition is
regulated by phosphorylation and reverted by PIP2 and adeno-
phostin. In living human sperm, we show that a permeable
MARCKS peptide abolishes stimulated acrosomal exocytosis and
abrogates calcium mobilization stimulated by progesterone.
Furthermore, we demonstrate that MARCKS phosphorylation
increases during acrosomal exocytosis. Altogether, these results
show that MARCKS is a negative modulator in acrosomal
exocytosis, probably by sequestering PIP2, and that its function is
regulated by phosphorylation. On the basis of the results presented
here and previous publications from others, we propose a working
model for MARCKS function in human sperm (see Fig. 6). In
resting sperm, a fraction of MARCKS is phosphorylated and
inactive, whereas another fraction is non-phosphorylated and
tightly associated to membranes sequestering PIP2. When sperm is
stimulated, acrosomal exocytosis is triggered by a cytoplasmic
increase of Ca2+ that –besides several other effects– activates a
conventional PKC, which phosphorylate MARCKS effector
domain. This phosphorylation would trigger the translocation of
phosphorylated MARCKS to cytosol and, as a consequence,
would increase the availability of PIP2. This lipid can then been
hydrolyzed by PLC to generate IP3 and DAG. IP3 is necessary to
elicit the efflux of Ca2+ from acrosome, which triggers the final
steps of acrosomal exocytosis [49]. Further studies will be required
to explore the untested details of this model.
Supporting Information
Figure S1 Specificity of anti-MARCKS and anti-phos-
pho-MARCKS antibodies. (A) Postnuclear extract from mouse
brain (1 mg de proteins, brain) or capacitated human sperm
(56106 cells, sperm) were resolved in a 10% gels, transferred to
PVDF membranes, and probes with two anti-MARCKS antibod-
ies against N-terminal domain, one from Abcam (anti-MARCKS,
left panel) and other from Santa Cruz (anti-MARCKS N-19, right
panel). In both cases, the primary antibody were preincubated
with an excess (1:10) of a blocking peptide corresponding to the N-
terminal of MARCKS (N-19 peptide, Santa Cruz) (ab+pep). The
signal reduction for anti-MARCKS antibody was 90% and for
anti-MARCKS N-19 was 75%. (B) Sperm were double-stained
with the anti-MARCKS antibody (Abcam) followed by an anti-
mouse-DyLight488 (a and b) or just with the anti-mouse-
DyLight488 (c and d). Acrosomes were stained with tetramethylr-
hodamine isothiocyanate-coupled L. culinaris agglutinin (TRITC-
LCA, b and d). (C) Sperm were double-stained with an anti-
phospho-MARCKS followed by an anti-rabbit-Cy3 (a and b), just
with the anti-rabbit-Cy3 (c and d) or anti-phospho-MARCKS
preincubated with an excess (1:10) of in vitro phosphorylated
MARCKS ED domain (phospho-MARCKS+pED, e and f).
Acrosomes were stained with FITC-PSA (b, d, and f). Bars = 5 mm
(TIF)
Figure S2 Recombinant MARCKS ED proteins diffuse
equally into permeabilized sperm. (A) Dot blot against
GST-fusion proteins: 200 ng purified GST fusion proteins of wild
type MARCKS ED (ED), phosphorylated MARCKS ED (pED),
MARCKS ED4A mutant (ED4A), MARCKS ED4D (ED4D),
and glutathione-S-transferase (GST) were immobilized on PVDF
membranes after blocking non-specific reactivity with 5% skim
milk dissolved in T-TBS. Membranes were incubated with anti-
GST antibody (0.016 mg/ml) from Novus Biologicals (Littleton,
CO) in blocking solution overnight at 4uC. A HRP-conjugated
goat anti-rabbit-IgG was used as secondary antibody during 1 h at
RT (1:20000 in blocking solution). The experiment was repeated
twice with similar results. (B) Capacitated and permeabilized
sperm were treated for 30 minutes at 37uC with 1 mM of each of
the following domains: wild type MARCKS ED (ED), phosphor-
ylated MARCKS ED (pED), MARCKS ED4A mutant (ED4A),
and MARCKS ED4D (ED4D). Then, sperm were washed twice
with PBS, incubated with an anti-GST antibody (166 nM, 60 min
at RT in 3% BSA), washed, and incubated with an anti-rabbit-
Cy3 antibody (60 min at RT 3 mg/ml in 1% BSA). After washing,
cells were fixed and mounted as described in Materials and
Methods. (C) Quantification of three independent experiments
shown in B. Bars represent mean6SEM. n/s, not significant
difference.
(TIF)
Figure S3 MARCKS peptide permeates into non-per-
meabilized sperm. (A) Non-permeabilized sperm were treated
for 30 minutes at 37uC with 4 mM permeable MARCKS ED
domain (ED-TMR) and then incubated with (+) or without (-)
0.5 mg/ml trypsin for 30 minutes at 37uC. Then, cells were fixed
and mounted as described in Materials and Methods. (B)
Quantification of tetramethylrhodamine-labeled acrosome sperm.
At least 300 cells were scored. The data represent the means6S.E
of at least four independent experiments. DIC, differential
interference contrast.
(TIF)
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